Image guided therapy: 3D navigation with light instead of x-ray

AI-enabled 3D device visualization using light instead of X-ray for endovascular procedures

Royal Philips has announced the expanded commercial availability of LumiGuide 3D Device Guidance across Europe and the United States. The system enables radiation-free* navigation, allowing physicians to visualize and guide devices inside the body using light instead of continuous X-ray. The announcement was made at RSNA 2025.

LumiGuide integrates with the company's Azurion platform and joins a portfolio of AI-enabled devices for image-guided procedures.

"I have done over 160 fenestrated and branched aortic procedures with LumiGuide and have found that the system improves efficiency, reduces the procedure time, and reduces time on the fluoroscopy pedal to near zero," said Adam W. Beck, MD, Professor and Director, Division of Vascular Surgery & Endovascular Therapy, University of Alabama at Birmingham.

By bringing this light-based navigation technology to more hospitals, we’re helping clinicians treat complex vascular disease with precision and safety, while reducing radiation risk for patients and teams in the lab
Atul Gupta

LumiGuide is powered by Philips Fiber Optic RealShape (FORS) technology. The system uses light to visualize the shape and position of LumiGuide wires and compatible endovascular catheters in real time and in 3D – without X-ray. By reflecting light along an optical fiber integrated into the guidewire, the system produces high-resolution, full-color images from any angle. AI algorithms align the images with the patient's anatomy.

According to a published study, complex aortic repair procedures can be performed 37% faster with up to 56% reduction in radiation exposure (DAP) using this technology.¹

“Moving LumiGuide from limited to full commercial availability is an important milestone in expanding access to advanced image-guided therapy,” said Stacey Beske, Business Leader Image-Guided Therapy Devices at Philips. “By bringing this light-based navigation technology to more hospitals, we’re helping clinicians treat complex vascular disease with precision and safety, while reducing radiation risk for patients and teams in the lab,” added Atul Gupta, MD, Chief Medical Officer Diagnosis & Treatment at Philips.

Following a limited market release in late 2023, LumiGuide will be commercially available starting January 2026 in key European markets and the United States.** To date, the system has been used in more than 2,000 clinical procedures.²

* While navigation with LumiGuide itself involves no radiation exposure, some clinical procedures may incorporate limited X-ray imaging for initial anatomical visualization.

** LumiGuide has FDA clearance and CE marking.

Source: Philips

02.12.2025